Gefitinib (ZD1839, Iressa™) as palliative treatment in recurrent or metastatic head and neck cancer

KIRBY, A. M ; A'HERN, R. P ; D'AMBROSIO, C ; TANAY, M ; SYRIGOS, K. N ; ROGERS, S. J ; BOX, C ; ECCLES, S. A ; NUTTING, C. M ; HARRINGTON, K. L

British journal of cancer, 2006-03, Vol.94 (5), p.631-636 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível